These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7228629)

  • 1. Once daily slow-release hydralazine in hypertension.
    O'Boyle CP; Kelly J; O'Brien ET; O'Malley K
    Ir Med J; 1981 Apr; 74(4):115-6. PubMed ID: 7228629
    [No Abstract]   [Full Text] [Related]  

  • 2. Hydralazine and beta-adrenergic blockade in the treatment of hypertension.
    Siitonen L; Jänne J; Keyriläinen O; Koskinen P; Leskinen O; Pitkäjärvi T; Reinikainen M
    Ann Clin Res; 1974 Dec; 6(6):341-6. PubMed ID: 4155933
    [No Abstract]   [Full Text] [Related]  

  • 3. [Ergometry in the assessment of antihypertensive treatment (author's transl)].
    Franz IW; Lohmann FW
    Dtsch Med Wochenschr; 1978 Sep; 103(38):1478-81. PubMed ID: 688878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of hydralazine-beta blockader association in hypertension of pregnancy].
    Monnier JC; Honore P; Lanciaux B; Boulogne M
    Lille Med; 1978; 23(9):660-6. PubMed ID: 32453
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of a slow release formulation of oxprenolol with conventional oxprenolol in the treatment of hypertension.
    O'Brien KP; Stephens EJ
    N Z Med J; 1976 Aug; 84(570):142-4. PubMed ID: 1069924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of refractory hypertension with a fixed oxprenolol/chlorthalidone/hydralazine combination. Results of an open multicenter trial].
    Krönig B; Wendt G
    Med Welt; 1983 Sep; 34(35):941-4. PubMed ID: 6355745
    [No Abstract]   [Full Text] [Related]  

  • 7. [Slow-release hydralazine in the treatment of essential arterial hypertension].
    Moscovici H; Yasbeck Júnior P; Fadul Neto J
    Arq Bras Cardiol; 1982 Sep; 39(3):197-9. PubMed ID: 7186366
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of hypertension with large doses of the beta-adrenergic blocking drug oxprenolol, alone, and in combination with the vasodilator dihydralazine.
    Tuckman J; Messerli F; Hodler J
    Clin Sci Mol Med Suppl; 1973 Aug; 45 Suppl 1():159s-61. PubMed ID: 4593561
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hydralazine in arterial hypertension. Randomized, double-blind comparison between conventional and slow-release preparations].
    Wulff K; Lenz K; Krogsgaard AR; Holst B
    Ugeskr Laeger; 1980 Jul; 142(29):1862-5. PubMed ID: 6996259
    [No Abstract]   [Full Text] [Related]  

  • 10. [Adelphan-esidrex in the treatment of hypertension].
    Shchepotin BM; Shchulipenko IM; Prisiazhniuk MS
    Vrach Delo; 1980 Dec; (12):27-30. PubMed ID: 7222574
    [No Abstract]   [Full Text] [Related]  

  • 11. [Slow-release oxprenolol and chlortalidone administered once daily in essential hypertension].
    Rossi A; Ziacchi V; Fracalossi C; Marino A; Lomanto B
    Minerva Cardioangiol; 1984 Dec; 32(12):949-62. PubMed ID: 6531101
    [No Abstract]   [Full Text] [Related]  

  • 12. Hydralazine in arterial hypertension. Randomized double-blind comparison of conventional/Slow-Release formulation and of b.i.d./q.i.d. dosage regimens.
    Wulff K; Lenz K; Krogsgaard AR; Holst B
    Acta Med Scand; 1980; 208(1-2):49-54. PubMed ID: 7435247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term experiences with an antihypertensive combination].
    Hilgert A; Horch G
    Med Welt; 1982 Jul; 33(29-30):1067-70. PubMed ID: 6750310
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of adelphan-esidrex with hypertension patients].
    Shvedenko LA; Parashchak AP; Kozak VP; Man'ko VI; Bigar' PV
    Vrach Delo; 1984 Apr; (4):27-30. PubMed ID: 6741046
    [No Abstract]   [Full Text] [Related]  

  • 15. Diuretics, beta blockers and vasodilators. Dosage in mild and moderate hypertension.
    Goble AJ
    Med J Aust; 1975 Jan; 1(SP2):14-7. PubMed ID: 1124020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Slow-Trasicor (sustained-release oxprenolol hydrochloride 160 mg) in the treatment of essential hypertension: a multicentre evaluation of 4,400 patients.
    Forrest WA
    Br J Clin Pract; 1977 Nov; 31(11):181-6. PubMed ID: 339937
    [No Abstract]   [Full Text] [Related]  

  • 17. Essential hypertension--effective therapy in private practice.
    Tanney H
    Rocky Mt Med J; 1969 Jun; 66(6):43-5. PubMed ID: 5807597
    [No Abstract]   [Full Text] [Related]  

  • 18. Severe hypertension in pregnancy: hydralazine or labetalol. A randomized clinical trial.
    Vigil-De Gracia P; Lasso M; Ruiz E; Vega-Malek JC; de Mena FT; López JC;
    Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):157-62. PubMed ID: 16621226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydralazine slow-release: observations on serum profile and clinical efficacy in man.
    Talseth T; Fauchald P; Pape JF
    Curr Ther Res Clin Exp; 1977 Feb; 21(2):157-68. PubMed ID: 403050
    [No Abstract]   [Full Text] [Related]  

  • 20. [Combined action of oxprenolol, hydrochlorothiazide and hydralazine in rats with metacorticoid induced hypertension].
    García Sacristán A
    Rev Clin Esp; 1980 Jun; 157(6):417-8. PubMed ID: 7414035
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.